Narrative review / 1999
Observational links between beta-carotene and lower lung cancer risk were contradicted by clinical trials showing harm from supplementation in smokers.
A review examined evidence regarding beta-carotene intake, blood status, fruit and vegetable intake, and lung cancer. More than 30 case-control and cohort studies indicated that higher consumption of vegetables, fruits, carotenoids, and higher blood beta-carotene concentrations were associated with lower lung cancer risk. In contrast, large controlled trials of beta-carotene supplementation did not support these benefits and instead provided striking evidence of adverse effects, including excess lung cancer incidence and overall mortality in smokers.
- Study type
- Narrative review
- Who was studied
- Human populations from observational studies and large controlled trials
- What was measured
- Lung cancer risk, incidence, and overall mortality
THE PAPER
Beta-carotene and lung cancer: a case study.
Albanes D. Am J Clin Nutr, 1999.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.